US Patent Issued to Regeneron Pharmaceuticals on March 18 for "Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments" (New York, New Jersey, Connecticut Inventors)

ALEXANDRIA, Va., March 19 -- United States Patent no. 12,251,440, issued on March 18, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments" was invented by Robert Babb (River Edge, N.J.), Alina Baum (Pleasantville, N.Y.), Gang Chen (Yorktown Heights, N.Y.), Cindy Gerson (Irvington, N.Y.), Johanna Hansen (Greenwich, Conn.), Tammy Huang (Cross River, N.Y.), Christos Kyratsous (Irvington, N.Y.), Wen-Yi Lee (New Hyde Park, N.Y.), Marine Malbec (Port Chester, N.Y.), Andrew Murphy (Croton-on-Hudson, N.Y.), William Olson (Yorktown Heights, N.Y.), Neil Stahl (Carmel, N.Y.) and George D. Yancopoulos (Yorktown Heights, N.Y.).

According to the abstract* release...